Stefan Halbherr

I focus on nanotech designs to make medicine
#InnoMedica #nanomedicine

#chemotherapy #cancer #neuroregeneration #neuroscience #neurodegeneration

[Stefan Halbherr @HalbherrStefan]

Happy to share our latest article investigating a novel concept for #nanomedicine in #oncology to treat solid #tumors more precisely while avoiding healthy tissues.

https://t.co/q0XCYtrzSQ

[Stefan Halbherr @HalbherrStefan]

@Rainmaker1973 Flu virus and adeno virus (AV) is NOT the same, dear Massimo 🤓

[The Science of Parkinson's @ScienceofPD]

Oooh, interesting: @HalbherrStefan & @InnoMedica team publish the results of their NEON trial - a single-center, open-label clinical phase I trial assessing the safety & tolerability of intravenous liposomal GM1 ("Talineuren") in 12 people with #Parkinsons
https://t.co/kt4nCK73ej

[Stefan Halbherr @HalbherrStefan]

@ScienceofPD @InnoMedica Thanks SoPD! That was fast 👀

Next part of the story is in the making with extended treatment periods up to 120+ weeks 🤓 data collection will be completed in June.

In parallel, we are gearing up for the placebo-controlled efficacy study. Should be able to start soon

[Stefan Halbherr @HalbherrStefan]

I can sort of relate to this 🤣
#Innovation

[Stefan Halbherr @HalbherrStefan]

@elonmusk @MarioNawfal How about solving it biologically and not electronically? I mean.. if you really embark on this mission, rather do it properly so that "the problem" is really solved.. I'd look at it this way.

[Stefan Halbherr @HalbherrStefan]

@ArgosBiotech @medical_xpress Fascinating! I often listen to music while working to mobilize energy inside me.

[Stefan Halbherr @HalbherrStefan]

the list is getting too long, I'll stop here knowing that many more would deserve being mentioned 💫

more info: https://t.co/v8tIygh6bY

[Stefan Halbherr @HalbherrStefan]

Let's GO!🤓 The clinical trial protocol for the efficacy study with InnoMedica Holding AG 's #neurology drug Talineuren has been signed by all parties.
🚀 Ready 2 submit 🚀
In this study, we'll discover if liposomal GM1 is a good option to treat #Parkinson's disease in an

[Stefan Halbherr @HalbherrStefan]

good reason to anticipate a positive outcome.

A big thanks 🫶 to the people making this a reality: Camille F. Peitsch Silvia Erni Claudine Bommer Céline Kaufmann Lisa Halbherr Petra Gottier, PhD Andreas Schittny Thomas Schick Jonas Zeller Pascal Halbherr ..

[Stefan Halbherr @HalbherrStefan]

Lipids are still underappreciated in so many ways!

[Massimo @Rainmaker1973]

Artist Markos Kay's “aBiogenesis” reimagines the origin of life in a rendering of the lipid world hypothesis: the first self-replicating, cell-like objects were composed of of fatty acids that could not dissolve in water.

[Stefan Halbherr @HalbherrStefan]

@twan_lammers @ESMI_society Exciting topic 🤓
>1% ID ending up in target tissue/tumors is just not a good result in my opinion. We urgently need to find better ways to bring more payload more precisely to where it is really needed.

[Stefan Halbherr @HalbherrStefan]

@PhysInHistory WHO is baking the cake and what oven is the cake in?
Dark matter and dark energy are the worst explanations I've encountered in my studies of natural sciences...

[Cure Parkinson's @CureParkinsonsT]

Rory Cellan-Jones’ newsletter (@ruskin147) today outlines the US National Plan to End Parkinson’s, an inspiring movement that reminds and encourages us to keep asking questions and striving for the change we all want to see. https://t.co/VIC6houE69

[Stefan Halbherr @HalbherrStefan]

Awesome!

[Michael Levin @drmichaellevin]

@DoctorJosh @_TechyBen https://t.co/7weZNtweOk

[Stefan Halbherr @HalbherrStefan]

Looks mesmerizing 🤓

[PNASNews @PNASNews]

Researchers grew rat neurons on a force sensor, which allowed them to discover that neurons develop tension after forming connections with other neurons, resulting in a contractile neural network. Without this contractility, neurons fail to fire. In PNAS: https://t.co/xZZBR5FKly

[Stefan Halbherr @HalbherrStefan]

or head over to: https://t.co/cvMKkKwiSd (completely new homepage will be online soon!) Hope you all finish the week well, happy 1st advent 🎄

[Stefan Halbherr @HalbherrStefan]

Our CNS/brain nano drug delivery system #patent has been granted by the Japan Patent Office 🤩
In my view, our approach to target the brain is unparalleled in terms of:
- simplicity
- efficacy
- and importantly, safety

[Stefan Halbherr @HalbherrStefan]

When fighting neurodegeneration (either chronic like Parkinson's or acute like stroke), evidence keeps piling up, showing that this is a good road forward. Read more here about GM1 and #parkinsonsdisease : https://t.co/DDf3muNamC